Document is current
Any future updates will be listed below
-
Authors
Kong, Li Ren https://orcid.org/0000-0001-7980-4666
Ong, Richard Weijie
Tan, Tuan Zea https://orcid.org/0000-0001-6624-1593
Mohamed Salleh, Nur Afiqah Binte
Thangavelu, Matan
Chan, Jane Vin
Koh, Lie Yong Judice
Periyasamy, Giridharan
Lau, Jieying Amelia
Le, Thi Bich Uyen
Wang, Lingzhi
Lee, Miyoung
Kannan, Srinivasaraghavan https://orcid.org/0000-0002-9539-5249
Verma, Chandra S.
Lim, Chwee Ming
Chng, Wee Joo
Lane, David P. https://orcid.org/0000-0003-0551-3545
Venkitaraman, Ashok
Hung, Huynh The
Cheok, Chit Fang
Goh, Boon Cher https://orcid.org/0000-0002-4107-102X
-
Funding
Funding for this research was provided by:
MOH | National Medical Research Council (NMRC/CSA-SI/0006/2016)
- License Information
-
More Information
Article History
Received: 4 March 2019
Accepted: 19 March 2020
First Online: 29 April 2020
Competing interests
: S.K. and C.S.V are the founders of Sinopsee Therapeutics, a biotech company developing molecules for therapeutic purposes. The remaining authors declare no competing interests.
